Compare Abbott India with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs FULFORD INDIA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA FULFORD INDIA ABBOTT INDIA/
FULFORD INDIA
 
P/E (TTM) x 54.3 398.8 13.6% View Chart
P/BV x 16.1 6.2 258.9% View Chart
Dividend Yield % 0.4 0.1 504.6%  

Financials

 ABBOTT INDIA   FULFORD INDIA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
FULFORD INDIA
Mar-14
ABBOTT INDIA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs8,834942 937.8%   
Low Rs5,458450 1,212.8%   
Sales per share (Unadj.) Rs1,731.1691.4 250.4%  
Earnings per share (Unadj.) Rs211.911.5 1,849.0%  
Cash flow per share (Unadj.) Rs219.915.4 1,431.6%  
Dividends per share (Unadj.) Rs65.002.00 3,250.0%  
Dividend yield (eoy) %0.90.3 316.5%  
Book value per share (Unadj.) Rs945.2380.0 248.7%  
Shares outstanding (eoy) m21.253.90 544.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.0 410.1%   
Avg P/E ratio x33.760.7 55.5%  
P/CF ratio (eoy) x32.545.3 71.7%  
Price / Book Value ratio x7.61.8 412.8%  
Dividend payout %30.717.4 175.8%   
Avg Mkt Cap Rs m151,8482,714 5,594.2%   
No. of employees `0003.50.4 784.9%   
Total wages/salary Rs m4,356505 862.5%   
Avg. sales/employee Rs Th10,555.56,073.0 173.8%   
Avg. wages/employee Rs Th1,249.91,137.4 109.9%   
Avg. net profit/employee Rs Th1,292.2100.7 1,283.5%   
INCOME DATA
Net Sales Rs m36,7862,696 1,364.3%  
Other income Rs m1,133125 903.4%   
Total revenues Rs m37,9192,822 1,343.8%   
Gross profit Rs m6,047-46 -13,033.0%  
Depreciation Rs m16915 1,113.2%   
Interest Rs m2310 236.8%   
Profit before tax Rs m6,98954 12,870.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,48510 25,887.5%   
Profit after tax Rs m4,50345 10,074.5%  
Gross profit margin %16.4-1.7 -955.3%  
Effective tax rate %35.617.7 201.1%   
Net profit margin %12.21.7 738.5%  
BALANCE SHEET DATA
Current assets Rs m27,6101,738 1,588.3%   
Current liabilities Rs m8,569545 1,573.1%   
Net working cap to sales %51.844.3 116.9%  
Current ratio x3.23.2 101.0%  
Inventory Days Days6048 124.2%  
Debtors Days Days274 636.4%  
Net fixed assets Rs m1,05712 8,881.4%   
Share capital Rs m21339 544.9%   
"Free" reserves Rs m19,8731,443 1,377.2%   
Net worth Rs m20,0861,482 1,355.3%   
Long term debt Rs m00-   
Total assets Rs m29,4092,077 1,416.1%  
Interest coverage x311.66.7 4,639.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.31.3 96.3%   
Return on assets %15.42.6 589.6%  
Return on equity %22.43.0 743.3%  
Return on capital %34.94.3 810.8%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m36917 2,145.1%   
Fx outflow Rs m4,918673 730.6%   
Net fx Rs m-4,549-656 693.6%   
CASH FLOW
From Operations Rs m4,99190 5,545.9%  
From Investments Rs m-2,570105 -2,457.0%  
From Financial Activity Rs m-1,428-14 10,127.7%  
Net Cashflow Rs m993181 550.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 7.9 3.8 207.9%  
FIIs % 0.1 0.1 100.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 21.2 80.7%  
Shareholders   18,270 4,783 382.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   GLENMARK PHARMA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  DIVIS LABORATORIES  J.B.CHEMICALS  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 1,375 Points; Nifty Ends Below 8,300 Mark(Closing)

Indian share markets witnessed selling pressure throughout the day and ended deep in the red with Sensex and Nifty witnessing a sharp fall during closing hours.

Related Views on News

PROCTER & GAMBLE HEALTH Surges by 6%; BSE HEALTHCARE Index Up 0.8% (Market Updates)

Mar 30, 2020 | Updated on Mar 30, 2020

PROCTER & GAMBLE HEALTH share price has surged by 6% and its current market price is Rs 3,499. The BSE HEALTHCARE is up by 0.8%. The top gainers in the BSE HEALTHCARE Index are PROCTER & GAMBLE HEALTH (up 6.3%) and ABBOTT INDIA (up 8.2%). The top losers are CADILA HEALTHCARE (down 0.1%) and J.B.CHEMICALS (down 0.2%).

TORRENT PHARMA Surges by 6%; BSE HEALTHCARE Index Up 1.6% (Market Updates)

Mar 30, 2020 | Updated on Mar 30, 2020

TORRENT PHARMA share price has surged by 6% and its current market price is Rs 1,967. The BSE HEALTHCARE is up by 1.6%. The top gainers in the BSE HEALTHCARE Index are TORRENT PHARMA (up 5.9%) and ABBOTT INDIA (up 7.7%). The top losers are NATCO PHARMA (down 0.5%) and BIOCON (down 0.6%).

IPCA LABS Surges by 6%; BSE HEALTHCARE Index Up 1.2% (Market Updates)

Mar 30, 2020 | Updated on Mar 30, 2020

IPCA LABS share price has surged by 6% and its current market price is Rs 1,317. The BSE HEALTHCARE is up by 1.2%. The top gainers in the BSE HEALTHCARE Index are IPCA LABS (up 5.8%) and ABBOTT INDIA (up 7.4%). The top losers are SANOFI INDIA (down 0.3%) and CAPLIN POINT (down 0.5%).

GSK PHARMA Surges by 6%; BSE HEALTHCARE Index Up 0.7% (Market Updates)

Mar 30, 2020 | Updated on Mar 30, 2020

GSK PHARMA share price has surged by 6% and its current market price is Rs 1,228. The BSE HEALTHCARE is up by 0.7%. The top gainers in the BSE HEALTHCARE Index are GSK PHARMA (up 6.4%) and ABBOTT INDIA (up 7.3%). The top losers are J.B.CHEMICALS (down 0.6%) and ALKEM LABORATORIES (down 0.9%).

BLUE DART EXPRESS Surges by 0%; BSE 500 Index Down 3.1% (Market Updates)

Mar 30, 2020 | Updated on Mar 30, 2020

BLUE DART EXPRESS share price has surged by 0% and its current market price is Rs 2,216. The BSE 500 is down by 3.1%. The top gainers in the BSE 500 Index are BLUE DART EXPRESS (down 0.2%) and ABBOTT INDIA (up 13.6%). The top losers are SKF INDIA and BLUE DART EXPRESS (down 0.2%).

More Views on News

Most Popular

This Crorepati Stock Could Be the Best Vaccine for Your Portfolio Against Coronavirus(Profit Hunter)

Mar 17, 2020

If there is one stock I had to recommend you amid Coronavirus outbreak, this would be it.

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Mar 30, 2020 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ORCHID PHARMA LTD COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS